Physician profile
Danielle Frank
NPI 1528144029
$5,309.69
in general payments reported to CMS, 2019-2025
21 companies · $654 in 2025
The $654 reported for 2025 was more than what 83% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $639 · 2020: $765 · 2021: $651 · 2022: $766 · 2023: $1,017 · 2024: $817 · 2025: $654.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,489.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,489.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $2,663.77 | 2019-2025 | Acuvue |
| Tarsus Pharmaceuticals, INC. | $410.04 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $322.35 | 2024-2025 | Miebo, Xiidra, Vyzulta |
| Novartis Pharmaceuticals Corporation | $278.59 | 2020-2023 | |
| Sun Pharmaceutical Industries INC. | $202.23 | 2021-2024 | Cequa |
| Alcon Vision LLC | $195.91 | 2019-2025 | Tryptyr |
| Coopervision INC. | $194.77 | 2019-2025 | Myday Contact Lens |
| Biotissue Holdings INC. | $175.18 | 2023 | |
| Oyster Point Pharma, INC. | $159.26 | 2022-2025 | Tyrvaya |
| Mallinckrodt Hospital Products INC. | $153.32 | 2023 | Acthar |
| Aerie Pharmaceuticals, INC. | $111.04 | 2019 | |
| Abbvie INC. | $108.12 | 2024-2025 | |
| Optos, INC. | $100.60 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $90.24 | 2019-2020 | |
| Dompe US, INC. | $35.18 | 2022-2025 | Oxervate |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $32.51 | 2024 | Vevye |
| Kala Pharmaceuticals, INC. | $20.65 | 2021 | |
| Carl Zeiss Meditec Ag | $17.20 | 2020 | |
| Alcon Research LLC | $16.02 | 2019 | |
| Shire North American Group INC | $12.49 | 2019 | |
| Visioneering Technologies, INC. | $10.22 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Frank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.